834
P. Radha Krishna et al. / Tetrahedron: Asymmetry 12 (2001) 829–837
chromatography (silica gel, hexane:EtOAc, 8:2) afforded
4a (0.27 g, 91%) as a syrup. [h]D=−20.9 (c 1.65, CHCl3);
1H NMR (200 MHz, CDCl3): l 8.05–7.95 (m, 1H, Ar-H),
7.85–7.65 (m, 2H, Ar-H), 7.56–7.45 (m, 1H, Ar-H), 6.38
(s, 1H, olefinic), 6.25–6.13 (m, 1H, olefinic), 5.85 (d, 0.7H,
J=3.81 Hz, H-1), 5.7 (d, 0.3H, J=3.81 Hz, H-1), 5.55
(s, 1H, benzylic), 5.3 (d, 0.7H, J=3.33 Hz, H-3), 5.22 (d,
0.3H, J=3.33 Hz, H-3), 4.48 (d, 0.7H, J=3.81 Hz, H-2),
4.4 (d, 0.3H, J=3.81 Hz, H-2), 4.2–3.95 (m, 4H, H-4, 5,
6, 6%), 3.4–3.25 (bs, 1H, -OH), 1.56–1.2 (br.s, 12H, 4CH3);
13C NMR (50 MHz, CDCl3): l 164.3, 141.2, 140.8, 136.2,
133.3, 128.7, 128.5, 127.0, 124.5, 112.1, 109.3, 104.9, 83.1,
79.7, 76.8, 72.5, 67.5, 67.1, 26.5 (2C), 26.0, 24.8; EIMS
(M+−15): 450; HRMS calcd for C22H27NO10 (M+−15):
450.140021. Found: 450.142441.
mmol) were added and the contents were stirred at room
temperature for 2 days. Work-up and purification as
reported for 4a gave 5a (1.18 g, 87%) as a syrup.
[h]D=−2.4 (c 1.2, CHCl3); 1H NMR (200 MHz, CDCl3):
l 8.25 (d, 2H, J=7.5 Hz, Ar-H), 7.65 (d, 2H, J=7.5 Hz,
Ar-H), 6.3 (d, 1H, J=5.5 Hz, olefinic), 5.95 (s, 1H,
olefinic), 5.85 (d, 0.3H, J=3.75 Hz, H-1), 5.8 (d, 0.7H,
J=3.75 Hz, H-1), 5.7 (d, 1H, J=3.75 Hz, benzylic), 5.3
(s, 1H, H-3), 4.5 (d, 0.3H, J=3.75 Hz, H-2), 4.4 (d, 0.7H,
J=3.75 Hz, H-2), 4.2–3.98 (m, 4H, H-4, 5, 6, 6%), 3.45
(br.d, 0.3H, J=5.5 Hz, -OH), 3.13 (br.d, -OH, J=5.5 Hz,
0.7H), 1.6–1.25 (br.s, 12H, 4CH3); 13C NMR (50 MHz,
CDCl3): l 162.5, 148.75, 141.0, 127.42, 127.28, 123.35
(2C), 112.19, 109.32, 106.2, 104.82, 83.62, 79.65, 76.34,
74.76, 69.63, 67.13, 64.74, 26.9, 26.46, 26.25, 25.97.
HREIMS calcd for C22H27NO10 (M+−15): 450.140021.
Found: 450.1386.
4.5. 6-[2,2-Dimethyl-(4R)-1,3-dioxolan-4-yl]-2,2-
dimethyl-(3aS,4R,6R,6aS)-perhydrofuro [3,4-d][1,3]-
dioxol-4-yl 2-hydroxy(2-nitrophenyl)methylacrylate 4b
Method B: A mixture of 1 (0.20 g, 0.64 mmol), 5 (0.12
g, 0.76 mmol) and DABCO (0.014 g, 0.13 mmol) in
DMSO (1 mL) were stirred for 24 h at room temperature.
The reaction mixture was treated with water (20 mL),
brine (25 mL) and extracted into ether (3×25 mL), the
combined organic layers were washed with water (2×25
mL), dried (Na2SO4) and concentrated under reduced
pressure. The residue was purified by column chromatog-
raphy to afford 5a (0.28 g, 95%) as a syrup, which was
identical spectroscopically to 5a prepared by method A.
To a solution of 2 (0.20 g, 0.64 mmol) in THF (2 mL),
4 (0.12 g, 0.76 mmol) and DABCO (0.014 g, 0.13 mmol)
were added and the reaction was performed as reported
for 4a, to give 4b (0.26 g, 88%) as a syrup. [h]D=+15.1
(c 2.1, CHCl3); 1H NMR (200 MHz, CDCl3): l 7.98–7.9
(m, 1-H, Ar-H), 7.65 (d, 2H, J=4.18 Hz, Ar-H), 7.5–7.4
(m, 1H, Ar-H), 6.42 (br.s, 1H, olefinic), 6.08 (s, 1H, H-1),
6.1 (s, 1H, olefinic), 5.91 (br.s, 1H, benzylic), 4.81–4.72
(m, 1H, H-3), 4.61 (br.d, 0.7H, J=5.12 Hz, H-2), 4.42
(br.d, 0.3H, J=5.12 Hz, H-2), 4.12–3.9 (m, 2H, H-4, 5),
3.7 (d, 1H, J=4.65 Hz, H-6), 3.42 (d, 1H, J=3.72 Hz,
H-6%), 1.45 (s, 6H, 2CH3), 1.31 (s, 6H); EIMS (M+−15):
450; HRMS calcd for C22H27NO10 (M+−15): 450.140021.
Found: 450.137848.
4.8. 6-[2,2-Dimethyl-(4R)-1,3-dioxolan-4-yl]-2,2-
dimethyl-(3aS,4R,6R,6aS)-perhydrofuro [3,4-d][1,3]-
dioxol-4-yl 2-hydroxy(4-nitrophenyl)methylacrylate 5b
To a solution of 2 (0.20 g, 0.64 mmol) in THF (2 mL)
5 (0.12 g, 0.76 mmol) and DABCO (0.014 g, 0.13 mmol)
were added and the contents stirred for 2 days at room
temperature. Work-up and purification as for 4a gave 5b
(0.29 g, 86%) as a syrup. [h]D=+20.8 (c 1.83, CHCl3); 1H
NMR (200 MHz, CDCl3): l 8.24 (d, 2H, J=9.52 Hz,
Ar-H), 7.6 (d, 2H, J=7.61 Hz, Ar-H), 6.38 (d, 1H,
J=3.81 Hz, olefinic), 6.16 (s, 1H, olefinic), 6.0 (s, 0.7H,
H-1), 5.9 (s, 0.3H, H-1), 5.64 (s, 1H, benzylic), 4.8 (m,
1H, H-3), 4.62 (d, 1H, J=5.71 Hz, H-2), 4.38 (m, 1H,
H-4), 4.1–3.85 (m, 3H, H-5, 6, 6%), 3.2 (br. s, 0.3H, -OH),
3.1 (br. s, 0.7H, -OH), 1.45–1.3 (br. s, 12H, 4CH3). EIMS
(M+−15): 450; HREIMS calcd for C22H27NO10 (M+−15):
450.140021. Found: 450.137848.
4.6. 5-tert-Butyldimethylsilyloxymethyl-2,2-dimethyl-
(3aR,6S,6aR)-perhydrofuro [2,3-d][1,3]-dioxol-6-yl 2-
hydroxy(2-nitrophenyl)methylacrylate 4c
To a solution of 3 (0.31 g, 0.86 mmol) in THF (3 mL),
4 (0.16 g, 1.04 mmol) and DABCO (0.02 g, 0.17 mmol)
were added and the contents were stirred for 6 days at
room temperature. Work-up and purification as
described for 4a gave 4c (0.38 g, 85%) as a syrup.
[h]D=−2.5 (c 1.1, CHCl3); 1H NMR (200 MHz, CDCl3):
l 7.6 (m, 2H, Ar-H), 7.4 (br.s, 2H, Ar-H), 6.32 (s, 1H,
olefinic), 6.2 (s, 1H, olefinic), 5.82 (d, 0.3H, J=4.38 Hz,
H-1), 5.75 (s, 1H, benzylic), 5.6 (d, 0.7H, J=4.38 Hz,
H-1), 5.38 (d, 0.3H, J=3.41 Hz, H-3), 5.28 (d, 0.7H,
J=3.41 Hz, H-3), 4.44 (d, 0.3H, J=3.89 Hz, H-2), 4.23
(d, 0.7H, J=3.89 Hz, H-2), 3.82 (m, 1H, H-4), 3.74–3.62
(m, 2H, H-5, 5%), 3.3–3.18 (br.s, 1H, -OH), 1.5 (br. s, 3H,
-CH3), 1.3 (br. s, 3H, -CH3), 1.01 (s, 9H, -C(CH3)3), 0.12
(s, 6H, 2CH3); anal. calcd for C24H35NO9Si: C, 56.56; H,
6.92. Found: C, 56.23; H, 6.16%.
4.9. 5-[2,2-Dimethyl-(4R)-1,3-dioxolan-4-yl]-2,2-
dimethyl-(3aR,6S,6aR)-perhydrofuro [2,3-d][1,3]-dioxol-
6-yl 2-(1-hydroxy-3-methylbutyl)acrylate 6a
To a solution of 1 (0.20 g, 64 mmol) in THF (2 mL) 6
(0.05 mL, 0.76 mmol) and DABCO (0.014 g, 0.13 mmol)
were added and the contents were stirred for 20 h at room
temperature. Work-up and purification as reported for
1
4a afforded 6a (0.17 g, 67%) as a syrup. H NMR (200
4.7. 5-[2,2-Dimethyl-(4R)-1,3-dioxolan-4-yl]-2,2-
dimethyl-(3aR,6S,6aR)-perhydrofuro [2,3-d][1,3]-dioxol-
6-yl 2-hydroxy(4-nitrophenyl)methylacrylate 5a
MHz, CDCl3): l 6.22 (s, 1H, olefinic), 5.82 (d, 1H,
J=3.63 Hz, H-1), 5.78 (s, 1H, olefinic), 5.28 (br.s, 1H,
allylic), 4.48 (d, 1H, J=3.63 Hz, H-2), 4.18–3.92 (m, 5H,
H-3, 4, 5, 6, 6%), 2.28 (br.s, 1H, -OH), 1.95–1.85 (m, 1H,
Me2CH-), 1.5 (s, 3H, CH3), 1.4 (s, 3H, CH3), 1.29 (br.s,
6H, 2CH3), 0.95–0.85 (2d, 6H, J=5.45, 5.9 Hz); EIMS
Method A: To a solution of 1 (0.92 g, 2.92 mmol) in THF
(6 mL) 5 (0.53 g, 3.51 mmol) and DABCO (0.07 g, 0.58